285 filings
Page 5 of 15
6-K
mtpgz23ao7dcp18i id
22 Nov 21
IMV Inc. Announces Chief Financial Officer to Retire
11:28am
6-K
ydbznio16k54kplygb86
12 Nov 21
IMV Inc. Announces Third Quarter 2021 Financial and Operational Update
9:08am
6-K
oqr18omb n6d9
10 Nov 21
Unaudited Interim Condensed Consolidated Financial Statements
5:14pm
6-K
7my184
9 Nov 21
Translational Data From the DeCidE1 Clinical Study in Patients with Advanced, Recurrent Ovarian Cancer to be Presented at SITC Annual Meeting
9:40am
6-K
1amnrc e2a
4 Nov 21
Report of Foreign Private Issuer for the Month of November, 2021
9:01am
6-K
90o 6bffr
7 Oct 21
Report of Foreign Private Issuer for the Month of October, 2021
10:53am
6-K
rpc98e9i1zem4g8ytj
1 Oct 21
Report of Foreign Private Issuer for the Month of October, 2021
9:30am
6-K
jwyh8dkjy1k8tpda wq
1 Oct 21
IMV’s DPX Delivery Technology to be Showcased in Two e-Posters at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
12:00am
6-K
h99zzmmzpbolil4i
1 Sep 21
IMV Inc. to Present at Three Investor Conferences in September
9:03am
6-K
4l5kp3p0m 18g2paaz
11 Aug 21
IMV Inc. Announces Second Quarter 2021 Financial and Operational Results
8:57am
6-K
lpbcekcs64kn4wt4
11 Aug 21
Management’s Responsibility for Financial Reporting
7:08am
6-K
uu79v9 zukrvfy
10 Aug 21
IMV Announces Final Topline Results of the DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer
9:01am
6-K
gg5 4vowof8c
5 Aug 21
IMV Announces CEO Transition
9:02am
6-K
99aryimq7 eq
3 Aug 21
Report of Foreign Issuer for the Month of August, 2021
8:58am
6-K
zjlbhuxv
29 Jul 21
IMV to Participate in the BTIG Virtual Biotechnology Conference
10:57am
6-K
csth7ch4nd
21 Jul 21
Current report (foreign)
4:26pm
6-K
88wjzzqccmo51
21 Jul 21
Current report (foreign)
4:25pm
6-K
ywken8 643nk
16 Jul 21
Current report (foreign)
4:59pm
SUPPL
l9q7xpcwmehz80kq30a
16 Jul 21
Supplemental materials (foreign)
3:41pm
6-K
agl3wmok zd5a2ideg
15 Jul 21
Current report (foreign)
4:43pm